Types of Penile Prosthesis Penile implants are currently available in a variety of
Types of Penile Prosthesis Penile implants are currently available in a variety of
forms, which can be categorized into two major types: semi-rigid, or inflatable, with a silicon or
Penile Prosthetic Surgery Michael Sohn and Antonio Martín-Morales
Surgical Treatment of Erectile Dysfunction 137
polyurethane jacket. Details of the available length end of each cylinder into each cylinder shaft. The and diameters can be found on the websites of the
newly developed Mentor two-piece penile prosthe- two manufacturing companies: American Medical
sis is called the Excel Resist® device. It consists of a Systems at www.visitams.com; and the Mentor
pair of inflatable cylinders, which are implanted into Corporation at www.mentorcorp.com. When im-
the corpora cavernosa, and a resi-pump that is planted into the corpora cavernosa, they can be
implanted into the scrotum. The cylinders and resi- manipulated by the patient to fit his needs. The Jonas
pump are preconnected and filled with sterile saline implant, produced in Germany, has a silver core and
during the manufacturing process. The volume of
a silicone covering [12]. A soft silicone implant was fluid in the reservoirs of both two-piece inflatable introduced by Subrini. Currently these devices are
penile prostheses is less than in the reservoir of the manufactured in France and sold under the names
three-piece prostheses. The lesser volume of the “SSDA” and “Virilis” in many countries [15]. These
two-piece reservoirs diminishes the difference implants may be indicated in the presence of residual
between rigidity and flaccidity of these systems, spongy erectile tissue, which permits tumescence
compared to the three-piece systems. and complimentary girth expansion around the
Three-piece inflatable implants are composed of central silicone support.
two cylinders, a scrotal pump and a reservoir, which The only “mechanical” prosthesis on the market is
is typically positioned either in the retrovesical space the Dura II, which has articulating segments of poly-
or within the peritoneal cavity. Three-piece implants ethylene held together by a central spring. These
manufactured by AMS are the 700 CX, 700 CXR and articulating segments are covered by a polytetrafluo-
Ultrex devices. The CXR cylinders have a narrow roethylene sleeve surrounded by a silicone jacket.
base and come in shorter lengths than the CX cylin- The Dura II prosthesis is a product of the American
ders. CX and CXR cylinders have a three-layer design Medical Systems (AMS). A similar device, called
consisting of an inner layer of elastic silicone, a “Genesis”, with a hydrophilic coating is planned by
middle layer of woven Dacron–Lycra and an outer the Mentor Corporation. This design provides posi-
layer of silicone. The inner layer fills with fluid to tional memory, allowing the prosthesis to remain
provide rigidity, the outer layer allows for capsule concealed when not in use, yet rigid during inter-
formation around, but not into, the prosthesis, and course [25]. These semi-rigid implants are cheaper
the middle layer permits controlled expansion of the than inflatable prostheses and easier to implant
cylinders. The recently introduced parylene coating because there is no pump or reservoir to place. Semi-
of the cylinders diminishes the risk of aneurysmal rigid prostheses may be implanted through a
dilatation of cylinders. In the CX and CXR cylinders, subcoronal, infrapubic or scrotal incision. Local
the middle layer is woven unidirectionally, permit- anesthesia may be used if the corpora cavernosa are
ting girth expansion but not length expansion. It is not too fibrotic and their dilatation is expected to be
commonly agreed that although very satisfactory easy.
results may be obtained in all subsets of patients, the Inflatable implants are available in two-piece or
CX implant is particularly useful for patients with three-piece models. Two-piece implants are made
Peyronie’s disease or any form of severe organic ED. by AMS and by the Mentor Corporation. The AMS
Patients who have significant scarring of the corpora Ambicor prosthesis consists of a pair of inflatable
cavernosa, e.g. after priapism or with extensive Pey- cylinders, which are implanted into the corpora cav-
ronie’s disease, or having a re-implant after previous ernosa, and a pump, which is implanted into the
removal of an infected prosthesis, may benefit from scrotum. The cylinders and pump are preconnected
an inflatable implant with narrow cylinders such as during the manufacturing process and the system is
the CXR, which requires dilation of the corpora cav- prefilled with sterile saline. To achieve an erection,
ernosa to only 10 mm. The only penile prosthesis the scrotal pump is squeezed and released several
that can lengthen with inflation is the AMS Ultrex times. This inflates the cylinders by transferring
prosthesis. This prosthesis also has three layers, but saline solution from a small reservoir located at the
the middle layer of Dacron–Lycra has a bi-directional
138 Chapter 12 weave that permits both length and girth expansion
Table 12.3 Implant rates of all manufacturers. (Personal of the cylinders. However, the Ultrex prosthesis is
data with permission of AMS, Germany [22].) not appropriate for patients with Peyronie’s disease
because these patients need greater stiffness than is
Year
Overall
USA Europe
provided by the Ultrex prosthesis.
Three-piece inflatable implants manufactured by 3.880
the Mentor Corporation share a similar design to the 3.960
previously described models. The main difference is
that the Mentor implants are made based of an inert
aromatic polyurethane polymer called Bioflex TM .
Compared to silicone, Bioflex TM has increased abra-
sion resistance and higher tensile strength. An addi-
tional feature of the current Mentor “Titan” or
three-piece inflatable prostheses, is a lockout valve that reduces the common phenomenon of auto- inflation of the prosthesis [16]. The lockout valve is
ments and in clinical use, is composed of 2 g of gen- also used in the two-piece Excel Resist® device. The
tamycin and 100 000 units of bacitracin in 1000 ml of Titan prostheses are also available in a narrow-base
saline [17,21].
version, which is best used in patients with severe Reduced infection rates have been reported fibrosis of the corpora cavernosa, as described above
recently for the AMS InhibiZone TM and the Mentor for the AMS CXR prosthesis.
Resist TM products [18,19,20]. The three-piece As infection is the most feared complication
implants of AMS and Mentor can be seen with their of penile prosthetic surgery, two- and three-piece
coatings in Figure 12.2. The two-piece device of implants specifically modified to reduce this risk
Mentor is also available with hydrophilic coating, have been recently introduced into clinical practice.
while the AMS two-piece Ambicor device is not. The InhibiZone TM prostheses by AMS are coated
Notably, to avoid elution of the coating prior to with a combination of rifampicin and minocycline to
implantation, the various components should not be inhibit bacterial growth. In these prostheses, the sur-
soaked in saline or other solutions for a prolonged faces of the prostheses, which come into contact with
period. However, conventional parenteral prophy- the adjacent tissue, are impregnated with quantifi-
lactic antibiotic protocols should be maintained. able doses of these antibiotics that elute into the area
Penile prosthesis implantation is a frequent opera- surrounding the prosthesis after surgery. Both
tion performed worldwide. The implant statistics drugs elute initially at high rates, with a significant
over the last years are summarized in Table 12.3. decrease in rifampicin after one and minocycline
The introduction of PDE5 inhibitors into the after seven days. The inhibitory effect of the Inhibi-
market in 1998 initially caused a significant drop in Zone TM treatment is greatest for Staphylococcus epider-
implant rates worldwide, but in more recent years a midis and Staphylococcus aureus [17,8].
constant increase of implants has been noted. Mentor has also developed a method to reduce
Seventy-five percent of penile implant sales are in penile prosthetic infection. This method uses an
the United States, where 90% of implants are three- intensely hydrophilic coating called Resist TM that
piece and two-piece devices. Outside the United is applied to the Titan and Excel prostheses. Its
States 40% of all implants are non-hydraulic devices increased lubrication has been shown to decrease
bacterial adherence in vitro. Furthermore this coating absorbs antibiotics that can elute into sur- rounding tissues over 24 to 72 hours to further
Patient and Implant Selection
decrease infection. An antibiotic-soaking solution, It is of critical importance to offer this treatment only which has been tested both in laboratory experi-
to properly selected patients, and furthermore to
Surgical Treatment of Erectile Dysfunction 139
Fig. 12.2 (a) AMS 700CX InhibiZone TM . (b) Mentor-Alpha 1. (c) Mentor Titan with Resist TM -Coating (here, colour- enhanced with methylene-blue).
select the model that best fits the patient’s needs and surement of the length of the penis. The length after anatomy. Patients who are eligible for a penile
prosthetic implantation is usually similar to the implant should be assessed with a detailed systemic
length of a completely stretched flaccid penis. It is medical and sexologic history [14]. Candidates for
worthwhile to spend time with the patient illustrat- penile prosthesis implantation should fulfill the
ing this concept because, commonly, patients have following criteria:
unrealistic expectations of penile length that cannot • Good general health
be met by any form of therapy. The physical exami- • Failure of medical therapy for ED or,
nation may also allow the detection of areas of signif- • Contra-indication to medical therapy of ED
icant scarring within the corpora cavernosa. Patients • Psychologic stability
with Peyronie’s disease may not report a penile bend • Patient and partner fully informed
even though they may have extensive corporal • Informed consent for surgery
fibrosis, which can ultimately limit the intraopera- • Unsuccessful trial of vacuum devices or at least
tive dilatation of the penis. In such cases, the final consideration of these devices [14,55]
penile length and girth may be unsatisfactory to the The complete medical assessment may include the
patient [55]. Preoperative identification of corporal following elements if they are available:
fibrosis and other factors that impact on postopera- • The international index of erectile function (IIEF)
tive results, plays a very important role in reducing or other validated questionnaires to objectively
or eliminating patients’ disappointment with post- assess severity of ED and subsequent postoperative
operative length and girth. During the physical outcome
examination, the manual dexterity of the patient • Penile colour Doppler sonography with intracor-
should be assessed, as it must be sufficient when an poral pharmacologic injection
inflatable prosthesis is used. Obesity may be a factor • Nocturnal penile tumescence test, especially
making the use of any prosthesis more difficult; this when the initial medical evaluation suggests the
is a physical feature that must be addressed [14]. possibility that the patient’s ED is predominantly
In patients with poorly-controlled or treated psychogenic
diabetes mellitus, it is wise to obtain a preliminary • In cases with medico–legal questions, a compre-
diabetologic consultation to normalize their glucose hensive diagnostic work up should be done [14]
metabolism. There is controversy as to whether
A thorough physical examination is very important. abnormally high serum glycosylated hemoglobin is a This should include an assessment or actual mea-
marker for higher risk of postoperative infection.
140 Chapter 12 Several investigators suggest that patients with
uncompensated diabetes mellitus may have an implant placed safely [23,55,57].
A critical point in the evaluation of the candidate for an implant is to identify active infections at the time of surgery. A urine culture is mandatory in all patients. Patients who have infectious lesions in the genital area or other local infections, and patients who have active systemic infections, should defer surgery until the infection has resolved. It has been suggested that patients should scrub their genitalia with an antiseptic solution during the five days prior to hospital admission, and should take an oral quinolone during the same period [14].
When an AMS three-piece implant is planned for
a patient with long penile length, the CX device should be used because CX devices provide better rigidity than Ultrex devices at longer penile length [56]. Patients with limited dexterity should be of- fered malleable devices. If the limited dexterity is due to a neurologic condition in which there is re- duced penile sensation, there is an increased risk of urethral or cutaneous erosion of the implant. In such cases, the surgeon should consider implanting somewhat shorter cylinders, to reduce the risk of erosion. In patients with severely scarred corpora, CXR or Mentor narrow-based devices should be used. If patients are disappointed postoperatively with their penile length, they can be advised that daily inflation of the prosthesis may produce cor- poral dilatation, and that surgical replacement with longer cylinders may be possible at a later time [24]. In patients undergoing secondary or repeat prosthesis implantation, the Ultrex device may be considered if preoperative physical examination re- veals a 2 cm or more difference between the non- stretched and stretched penile length. However, Ultrex cylinders should not be used in patients with Peyronie’s disease.
In patients who have had retropubic prostatec- tomy, cystectomy or other causes of perivesical scarring, two-piece implants offer the advantage of not requiring retropubic placement of an implant reservoir. However, the difference in rigidity and girth between the inflated and deflated states of two-piece penile prostheses is limited compared to three-piece implants. Alternatively, intra-
abdominal, rather than retropubic, placement of the reservoir of a three-piece device can be chosen for the patient with retropubic fibrosis [25].